We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

5 hedge funds and large institutions have $11.1M invested in Plus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

73% less capital invested

Capital invested by funds: $41.4M → $11.1M (-$30.3M)

91% less call options, than puts

Call options by funds: $8K | Put options by funds: $85K

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$8K
Puts
$85K
Net Calls
-$77K
Net Calls Change
+$320K

Top Buyers

Rank Fund Capital Flow
1
GCM
Goldman Capital Management
New York
+$4.54M

Top Sellers

Rank Fund Capital Flow
1
RCM
Rotella Capital Management
Washington
-$151K
2
TC
TFS Capital
Pennsylvania
-$51K
3
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$35K
4
Prudential Financial
Prudential Financial
New Jersey
-$27K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$26K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$14K – – –
LPL Financial
52
LPL Financial
California
$12K – – –
Wells Fargo
53
Wells Fargo
California
$12K – – –
GC
54
Guggenheim Capital
Illinois
$11K – – –
Principal Financial Group
55
Principal Financial Group
Iowa
$10K – – –
M&T Bank
56
M&T Bank
New York
$9K – – –
SG Americas Securities
57
SG Americas Securities
New York
$9K – – –
Citadel Advisors
58
Citadel Advisors
Florida
$6K – – –
Citigroup
59
Citigroup
New York
$5K – – –
U
60
UBS
Switzerland
$5K – – –
TDC
61
Thompson Davis & Co
Virginia
$4K – – –
BNP Paribas Financial Markets
62
BNP Paribas Financial Markets
France
$3.74K – – –
SM
63
Sabby Management
Florida
$2.36K – – –
Ameriprise
64
Ameriprise
Minnesota
$2K – – –
BlackRock
65
BlackRock
New York
$1K – – –
WA
66
Waverly Advisors
Alabama
$1K – – –
Manulife (Manufacturers Life Insurance)
67
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$25 – – –
UB
68
UMB Bank
Missouri
$24 – – –
Bank of Montreal
69
Bank of Montreal
Ontario, Canada
– -$4K – –
BRWA
70
B. Riley Wealth Advisors
Florida
– -$2.85K – –
Dimensional Fund Advisors
71
Dimensional Fund Advisors
Texas
– -$26K – –
GSC
72
Ground Swell Capital
South Carolina
– -$1K – –
LTFS
73
Ladenburg Thalmann Financial Services
Florida
– -$2K – –
Prudential Financial
74
Prudential Financial
New Jersey
– -$27K – –
RCM
75
Rotella Capital Management
Washington
– -$151K – –
1 2
3
4

PSTV Hedge Fund Activity: Q3 2014 in Review

5 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q3 2014, worth a combined $11.1M — down 73% from $41.4M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PSTV positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Goldman Capital Management, opening a new position worth an estimated $4.54M. The largest seller was Rotella Capital Management, cutting an estimated $151K.

  • 5 institutional investors held Plus Therapeutics (PSTV) as of Q3 2014, up from 4 in Q2 2014.
  • Funds reported $11.1M of Plus Therapeutics stock for Q3 2014, down 73% quarter-over-quarter.
  • 1 fund opened new Plus Therapeutics positions in Q3 2014 and 0 closed out, a net change of +1 holder.
  • The largest Plus Therapeutics buyer in Q3 2014 was Goldman Capital Management, an estimated $4.54M added.
  • The largest Plus Therapeutics seller in Q3 2014 was Rotella Capital Management, an estimated $151K sold.

Based on aggregated 13F filings for Q3 2014.